[EN] COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS [FR] COMPOSÉS ÉTANT DES AGENTS DE MODULATION DE S1P ET/OU DES AGENTS DE MODULATION D'ATX
[EN] COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS [FR] COMPOSÉS ÉTANT DES AGENTS DE MODULATION DE S1P ET/OU DES AGENTS DE MODULATION D'ATX
[EN] MODULATORS OF THE INTEGRATED STRESS PATHWAY<br/>[FR] MODULATEURS DE LA VOIE DE RÉPONSE INTÉGRÉE AU STRESS
申请人:CALICO LIFE SCIENCES
公开号:WO2017193063A1
公开(公告)日:2017-11-09
Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.
本文提供了用于调节综合应激反应(ISR)并治疗相关疾病、疾患和症状的化合物、组合物和方法。
SUBSTITUTED N-BICYCLO-2-ARYL-QUINOLIN-4-CARBOXAMIDES AND USE THEREOF
申请人:BAYER PHARMA AKTIENGESELLSCHAFT
公开号:US20180036300A1
公开(公告)日:2018-02-08
The present application relates to novel substituted N-bicyclo-2-arylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of fibrotic and inflammatory disorders.
[EN] SUBSTITUTED CYCLOLAKYLS AS MODULATORS OF THE INTEGRATED STRESS PATHWAY<br/>[FR] CYCLOLALKYLES SUBSTITUÉS EN TANT QUE MODULATEURS DE LA VOIE DE STRESS INTÉGRÉE
申请人:CALICO LIFE SCIENCES LLC
公开号:WO2020223536A1
公开(公告)日:2020-11-05
Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases, disorders and conditions.
本文提供了用于调节综合应激反应(ISR)并治疗相关疾病、疾病和症状的化合物、组合物和方法。
COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS
申请人:BIOGEN IDEC MA INC.
公开号:US20150203515A1
公开(公告)日:2015-07-23
Compounds of formula (I) can modulate the activity of one or more SIP receptors and/or the activity of autotaxin (ATX).
式(I)的化合物可以调节一个或多个SIP受体的活性和/或自体向素(ATX)的活性。
Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof
申请人:BAYER PHARMA AKTIENGESELLSCHAFT
公开号:US10117864B2
公开(公告)日:2018-11-06
The present application relates to novel substituted N-bicyclo-2-arylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of fibrotic and inflammatory disorders.